SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-21-055066
Filing Date
2021-10-28
Accepted
2021-10-28 14:54:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea149498-defa14a_inmed.htm DEFA14A 37717
2 GRAPHIC image_001.jpg GRAPHIC 5278
  Complete submission text file 0001213900-21-055066.txt   46110
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-39685 | Film No.: 211357369
SIC: 2834 Pharmaceutical Preparations